The advance of high-performance computing (HPC), high-performance data analytics (HPDA) and AI and their synergetic integration into workflows has revolutionized numerous industries, amongst others the medical and pharmaceutical sectors. In this special section of Technology and Health Care, we delve into the remarkable advancements and potential of HPC, HPDA and AI (together termed HPC+) in driving innovation, improving patient outcomes, and accelerating drug discovery. The articles in this issue shed light onto the potential of HPC+ in addressing several critical areas, including medical imaging, personalized medicine, drug discovery, and clinical as well as political decision support.
Keywords: Computer simulation; big data; computer-assisted decision making; computer-assisted diagnosis; drug development; image processing; precision medicine.